You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Follow-up of Patients who are Clinically Disease-free After Primary Treatment for Fallopian Tube, Primary Peritoneal, and Epithelial Ovarian Cancer

ID: 4-22 Nov 2015
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
T. Le, E.B. Kennedy, J. Dodge, L. Elit , Ovarian Follow-up Guideline Expert Panel

Guideline Object

To make recommendations for appropriate follow-up of women with confirmation of remission, after surgery and first-line chemotherapy, for fallopian tube, primary peritoneal, or epithelial ovarian cancer.

Of interest are appropriate intervals and methods, as well as who should conduct the follow-up examinations.

Patient Population

Women who have received confirmation of clinical complete remission (i.e., are disease-free) after surgery and first-line chemotherapy for fallopian tube, primary peritoneal, or epithelial ovarian cancer.

Disease-free status is determined according to the standard procedure at the unit where treatment was provided and may include negative clinical examinations, negative imaging investigations, and/or negative tumour marker results.

Intended Guideline Users

Clinicians who provide follow-up examinations to the target population, and may include gynecologic oncologists, medical oncologists, specialist nurses, gynecologists, family physicians, or other clinicians who deliver follow-up cancer care in the province of Ontario.

Research Question(s)

In women with confirmation of remission after surgery and first-line chemotherapy for epithelial ovarian cancer, what are the differences in survival rate, QOL, and level of anxiety associated with different follow-up intervals and methods for detection of recurrence?

pdf download Summary (PDF) (287.75 KB)
pdf download Full Report (PDF) (597.71 KB)